Nanobiotix Net Receivables from 2010 to 2026
| NBTX Stock | USD 25.34 0.85 3.47% |
Net Receivables | First Reported 2011-12-31 | Previous Quarter 8.5 M | Current Value 1.8 M | Quarterly Volatility 2.7 M |
Check Nanobiotix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanobiotix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2 M, Interest Expense of 9.8 M or Selling General Administrative of 13 M, as well as many indicators such as Dividend Yield of 5.0E-4, Invested Capital of 0.0 or Average Payables of 1.9 M. Nanobiotix financial statements analysis is a perfect complement when working with Nanobiotix Valuation or Volatility modules.
Nanobiotix | Net Receivables | Build AI portfolio with Nanobiotix Stock |
The evolution of Net Receivables for Nanobiotix provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Nanobiotix compares to historical norms and industry peers.
Latest Nanobiotix's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Nanobiotix over the last few years. It is Nanobiotix's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nanobiotix's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Nanobiotix Net Receivables Regression Statistics
| Arithmetic Mean | 3,053,346 | |
| Geometric Mean | 832,715 | |
| Coefficient Of Variation | 117.01 | |
| Mean Deviation | 2,846,533 | |
| Median | 1,346,525 | |
| Standard Deviation | 3,572,743 | |
| Sample Variance | 12.8T | |
| Range | 10.3M | |
| R-Value | 0.81 | |
| Mean Square Error | 4.6T | |
| R-Squared | 0.66 | |
| Significance | 0.000074 | |
| Slope | 574,944 | |
| Total Sum of Squares | 204.2T |
Nanobiotix Net Receivables History
About Nanobiotix Financial Statements
Nanobiotix investors use historical fundamental indicators, such as Nanobiotix's Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nanobiotix. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 9.8 M | 10.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nanobiotix Stock Analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.